Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: A microiontophoretic study in the rat
- 1 June 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 112 (3) , 415-418
- https://doi.org/10.1016/0014-2999(85)90790-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984
- Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptorsNeuropharmacology, 1984
- Behavioural effects of PK 8165 that are not mediated by benzodiazepine binding sitesNeuroscience Letters, 1984
- The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivoNeuroscience Letters, 1984
- PK 8165 and PK 9084, two quinoline derivatives with anxiolytic properties, antagonize the anticonvulsant effects of diazepamBrain Research, 1983
- Molecular substrates of anxiety: Clues from the heterogeneity of benzodiazepine receptorsLife Sciences, 1982
- The effect of GABA on binding of two novel non-benzodiazepines, PK 8165 and CGS 8216, to benzodiazepine receptors in the rat brainLife Sciences, 1982
- Selective antagonists of benzodiazepinesNature, 1981
- Multiple benzodiazepine receptors: Evidence of a dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives)Life Sciences, 1981
- The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampusBrain Research, 1981